Please provide your email address to receive an email when new articles are posted on . Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a society of cornea, cataract and ...
A San Francisco biotech is trying to cure HIV with the gene-editing tool CRISPR. Excision BioTherapeutics launched the first-ever CRISPR study for HIV patients on Thursday. The company's CEO hopes it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results